Associations between body mass index and the risk of renal events in patients with type 2 diabetes

Associations between body mass index and the risk of renal events in patients with type 2 diabetes

<p>Background/Objectives: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.</p><p> Subjects/...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Mohammedi, K, Chalmers, J, Herrington, W, Li, Q, Mancia, G, Marre, M, Poulter, N, Rodgers, A, Williams, B, Perkovic, V, Coresh, J, Woodward, M
Format:	Journal article
Wydane:	Nature Publishing Group 2018

Podobne zapisy

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
od: Kamel Mohammedi, i wsp.
Wydane: (2021-01-01)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
od: Mohammedi, K, i wsp.
Wydane: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
od: Jun, M, i wsp.
Wydane: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
od: Jun, M, i wsp.
Wydane: (2017)

Lowering blood pressure reduces renal events in type 2 diabetes.
od: de Galan, B, i wsp.
Wydane: (2009)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
od: Ohkuma, T, i wsp.
Wydane: (2019)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
od: Woodward, M, i wsp.
Wydane: (2016)

Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
od: Herrington, W, i wsp.
Wydane: (2017)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
od: Atkins, A, i wsp.
Wydane: (2017)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
od: Blomster, J, i wsp.
Wydane: (2017)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
od: Ohkuma, T, i wsp.
Wydane: (2018)

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes
od: Mohammedi, K, i wsp.
Wydane: (2016)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
od: Ohkuma, T, i wsp.
Wydane: (2017)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
od: Perkovic, V, i wsp.
Wydane: (2013)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
od: Mohammedi, K, i wsp.
Wydane: (2016)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
od: van Steen, S, i wsp.
Wydane: (2018)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
od: Woodward, M, i wsp.
Wydane: (2016)

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study
od: Thomas, M, i wsp.
Wydane: (2018)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
od: Rahman, F, i wsp.
Wydane: (2019)

The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma
od: Zheng Y, i wsp.
Wydane: (2019-05-01)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
od: Lv, J, i wsp.
Wydane: (2012)

Impact of Body Mass Index on Survival of Metastatic Renal Cancer
od: Jose Javier Salgado, i wsp.
Wydane: (2021-07-01)

Association of Body Mass Index and Food Intake with Renal Cell Carcinoma
od: Negin Basiri, i wsp.
Wydane: (2015-02-01)

CORRELATION BETWEEN ACUTE CORONARY EVENTS AND BODY MASS INDEX VALUES
od: Maria Marilena Frunzulică, i wsp.
Wydane: (2019-09-01)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
od: Patel, A, i wsp.
Wydane: (2007)

Severe Hypoglycemia and Risks of Vascular Events and Death
od: Zoungas, S, i wsp.
Wydane: (2010)

Visceral Adiposity Index, Body Fat Index and Fat Mass In Patients with Chronic Renal Failure
od: Sema Kunt, i wsp.
Wydane: (2020-06-01)

Plasma lipidomic profiles improve upon traditional risk factors for the prediction of cardiovascular events in type 2 diabetes
od: Alshehry, Z, i wsp.
Wydane: (2016)

Strategies to meet the need for long-term data
od: Chalmers, J, i wsp.
Wydane: (2016)

Body mass index and comorbidity are associated with postoperative renal function after nephrectomy
od: Lael Reinstatler, i wsp.
Wydane: (2015-08-01)

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
od: Alexander Hintze Hillers, i wsp.
Wydane: (2024-08-01)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
od: Zoungas, S, i wsp.
Wydane: (2009)

Appearance Comparison, Body Appreciation, and Adolescent Depressive Symptoms: Roles of Gender, Age, and Body-Mass Index
od: Zheng Q, i wsp.
Wydane: (2024-10-01)

Body mass index and age as determinants of renal hemodynamics and reserve capacity after living kidney donation
od: Rook, M, i wsp.
Wydane: (2006)

Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events
od: Herrington, W, i wsp.
Wydane: (2014)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
od: Shoujiang You, i wsp.
Wydane: (2025-02-01)

Sex-specific body mass index to optimize low correlation with height and high correlation with fatness: a UK Biobank study
od: Feng, Q, i wsp.
Wydane: (2023)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
od: Hua, X, i wsp.
Wydane: (2020)

Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers
od: Nicola Dalbeth, i wsp.
Wydane: (2020-11-01)

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
od: Iurilli, MLC, i wsp.
Wydane: (2021)